Literature DB >> 8198607

Human melanoma cells express functional endothelin-1 receptors.

J J Yohn1, C Smith, T Stevens, T A Hoffman, J G Morelli, D L Hurt, M Yanagisawa, M A Kane, M R Zamora.   

Abstract

Current evidence suggests that endothelium-derived factors enhance human melanoma vascular invasion. Therefore, we studied human melanoma cell expression of receptors to the endothelium-derived peptide, endothelin-1 (ET-1), and determined if they respond to ET-1 with proliferation and chemokinesis. Human metastatic melanoma cell lines were found to have specific, saturable, high affinity ET-1 binding. Northern analysis and competitive inhibition studies confirmed that melanoma cells express the ETB receptor isoform. Ten nanomolar ET-1 caused an 8.2 to 25.5-fold increase in intracellular free calcium. ET-1 was found to be a weak mitogen for melanoma cells, however, melanoma cell chemokinesis was significantly increased by ET-1. These data suggest that ET-1 may be involved in providing a chemokinetic and growth factor environment that enhances perivascular proliferation and invasiveness of melanoma cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8198607     DOI: 10.1006/bbrc.1994.1722

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Rendomab B4, a monoclonal antibody that discriminates the human endothelin B receptor of melanoma cells and inhibits their migration.

Authors:  Aurélie Borrull; Bertrand Allard; Anne Wijkhuisen; Amaury Herbet; Patricia Lamourette; Wided Birouk; Denis Leiber; Zahra Tanfin; Frédéric Ducancel; Didier Boquet; Jean-Yves Couraud; Philippe Robin
Journal:  MAbs       Date:  2016-07-08       Impact factor: 5.857

2.  An endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo.

Authors:  R Lahav; G Heffner; P H Patterson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

3.  Endothelin receptor antagonists: rationale, clinical development, and role in prostate cancer therapeutics.

Authors:  Snehal G Thakkar; Toni K Choueiri; Jorge A Garcia
Journal:  Curr Oncol Rep       Date:  2006-03       Impact factor: 5.075

4.  Inhibition of endothelin-B receptor signaling synergizes with MAPK pathway inhibitors in BRAF mutated melanoma.

Authors:  Alexander Schäfer; Benedicte Haenig; Julie Erupathil; Panja Strickner; Daniela Sabato; Richard W D Welford; Lhéanna Klaeylé; Elise Simon; Clemens Krepler; Patricia Brafford; Min Xiao; Meenhard Herlyn; Matthias Gstaiger; Francois Lehembre; Imke Renz
Journal:  Oncogene       Date:  2021-01-26       Impact factor: 9.867

5.  Expression of endothelin system in neuroblastic tumors: close association of endothelin-1 and endothelin B receptor expression with differentiation of tumor cells.

Authors:  Nobuo Hoshi; Takashi Sugino; Toshimitsu Suzuki
Journal:  Med Mol Morphol       Date:  2009-06-18       Impact factor: 2.309

6.  The expression of endothelin receptor B in melanoma cells A375 and Sk-mel-1 and the proliferative effects of endothelin 3 on A375 cells.

Authors:  Nengxing Lin; Changzheng Huang; Jin Tian; Juan Tao; Jin Zhang; Lingyun Yang; Yan Li; Yeqiang Liu; Siyuan Chen; Guanxin Shen; Jiawen Li; Chunsen Wang; Yating Tu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-10

7.  Null mutation of endothelin receptor type B gene in spotting lethal rats causes aganglionic megacolon and white coat color.

Authors:  C E Gariepy; D T Cass; M Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

8.  UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells.

Authors:  Sumayah Jamal; Robert J Schneider
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

9.  Endothelin 3 promotes neural crest cell proliferation and mediates a vast increase in melanocyte number in culture.

Authors:  R Lahav; C Ziller; E Dupin; N M Le Douarin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

10.  Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma.

Authors:  Y F Zhang; S Jeffery; S A Burchill; P A Berry; J C Kaski; N D Carter
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.